ConductScience.org, home

Paper37908366

Novel lipid antigens for NKT cells in cancer.

Lee MS and 1 other. Front Immunol, 2023. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Novel lipid antigens for NKT cells in cancer. Papers, record 37908366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37908366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel lipid antigens for NKT cells in cancer.
PubMed
Journal
Front Immunol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2024-09-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee MSMichael S
2Webb TJTonya J

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Natural Killer T-CellsMajor topic
NeoplasmsMajor topic
Humans
Antigen Presentation
Lipids

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA134274NCI NIH HHSUnited StatesP30CA134274PubMed and NIHNIH RePORTER
R25 GM113262NIGMS NIH HHSUnited StatesR25GM113262PubMed and NIHNIH RePORTER

Download CSV of grants

References96

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122767159Lipidomic analysis of phospholipids from human mammary epithelial and breast cancer cell lines.J Cell Physiol2013https://conductscience.org/library/papers/22767159PubMed
226862848Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.Oncotarget2016https://conductscience.org/library/papers/26862848PubMed
326297715The alpha and omega of galactosylceramides in T cell immune function.J Biol Chem2015https://conductscience.org/library/papers/26297715PubMed
428851309Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.BMC Cancer2017https://conductscience.org/library/papers/28851309PubMed
521653685Enhanced antitumor effects by chemical modified IGb3 analogues.Mol Cancer Ther2011https://conductscience.org/library/papers/21653685PubMed
627297969Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.Pathog Dis2016https://conductscience.org/library/papers/27297969PubMed
715197224The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.J Exp Med2004https://conductscience.org/library/papers/15197224PubMed
817339459CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytes.J Immunol2007https://conductscience.org/library/papers/17339459PubMed
930822302TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells.PLoS Biol2019https://conductscience.org/library/papers/30822302PubMed
1012023333Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells.J Immunol2002https://conductscience.org/library/papers/12023333PubMed
1112847141Cross-presentation of disialoganglioside GD3 to natural killer T cells.J Exp Med2003https://conductscience.org/library/papers/12847141PubMed
1217409402Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.Cancer Res2007https://conductscience.org/library/papers/17409402PubMed
1322932803NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.Blood2012https://conductscience.org/library/papers/22932803PubMed
1414557411The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.J Exp Med2003https://conductscience.org/library/papers/14557411PubMed
1516087713Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.J Exp Med2005https://conductscience.org/library/papers/16087713PubMed
1623100308Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma.Blood2013https://conductscience.org/library/papers/23100308PubMed
1723039336Comprehensive lipidome profiling of isogenic primary and metastatic colon adenocarcinoma cell lines.Anal Chem2012https://conductscience.org/library/papers/23039336PubMed
1826969612The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.Cancer Immunol Immunother2016https://conductscience.org/library/papers/26969612PubMed
193496420Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes.J Exp Med1987https://conductscience.org/library/papers/3496420PubMed
2029163518Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.Front Immunol2017https://conductscience.org/library/papers/29163518PubMed

See all 96 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42558863Advances in Lipid Metabolism Reprogramming in Hepatocellular Carcinoma.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42558863PubMed
41908667Low-dose decitabine increases peripheral NKT-like cell proportions in patients with chronic myeloid neoplasms.Cancer Pathog Ther2026https://conductscience.org/library/papers/41908667PubMed
41827836Innate-like T Cell Biology in the Tumor Microenvironment Implications for Cancer Immunotherapy.Cells2026https://conductscience.org/library/papers/41827836PubMed
41375063Natural Killer (NK) Cell-Based Therapies Have the Potential to Treat Ovarian Cancer Effectively by Targeting Diverse Tumor Populations and Reducing the Risk of Recurrence.Cancers (Basel)2025https://conductscience.org/library/papers/41375063PubMed
41200171Innate immunity in tumors: roles and therapeutic targets.Front Immunol2025https://conductscience.org/library/papers/41200171PubMed
41194129Innovative gene engineering strategies to address tumor antigen escape in cell therapy.J Transl Med2025https://conductscience.org/library/papers/41194129PubMed
41148807Evolutionary Perspective of Nonclassical MHC Class I and Innate-like T Cells Relevance in Immune Surveillance.Cells2025https://conductscience.org/library/papers/41148807PubMed
40746558Unconventional T cells in anti-cancer immunity.Front Immunol2025https://conductscience.org/library/papers/40746558PubMed
40718496CAR-iNKT cells: redefining the frontiers of cellular immunotherapy.Front Immunol2025https://conductscience.org/library/papers/40718496PubMed
40698085Global trends and frontiers in iNKT cells: a bibliometric and visualized analysis.Front Immunol2025https://conductscience.org/library/papers/40698085PubMed
40583406NKT cells-a generalist in disease treatment and a new key to unlock immunotherapy.Immunotherapy2025https://conductscience.org/library/papers/40583406PubMed
40456901Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy.Nat Rev Cancer2025https://conductscience.org/library/papers/40456901PubMed
40095325OMIP-111: Immune-Profiling of T Helper 1 (Th1), Th2, and Th17 Signatures in Murine Splenocytes by Targeting Intracellular Cytokines.Cytometry A2025https://conductscience.org/library/papers/40095325PubMed
39537239CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.Gut2025https://conductscience.org/library/papers/39537239PubMed
39508915SPINK5 is a key regulator of eosinophil extracellular traps in head and neck squamous cell carcinoma.Discov Oncol2024https://conductscience.org/library/papers/39508915PubMed
39170618Traversing the bench to bedside journey for iNKT cell therapies.Front Immunol2024https://conductscience.org/library/papers/39170618PubMed
38885470NKT Cells and Other Innate T Cells: The Immune Cells That Do Not Follow the Rules.J Immunol2024https://conductscience.org/library/papers/38885470PubMed
38736328Human CD4+ iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma.Immunology2024https://conductscience.org/library/papers/38736328PubMed

Download CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD1D912PubTator's text mininghttps://conductscience.org/library/genes/912NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTSS1520PubTator's text mininghttps://conductscience.org/library/genes/1520NCBI Gene
CXADRP1653108PubTator's text mininghttps://conductscience.org/library/genes/653108NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FASLG356PubTator's text mininghttps://conductscience.org/library/genes/356NCBI Gene
FASN2194PubTator's text mininghttps://conductscience.org/library/genes/2194NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL133596PubTator's text mininghttps://conductscience.org/library/genes/3596NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
MGLL11343PubTator's text mininghttps://conductscience.org/library/genes/11343NCBI Gene
PC5091PubTator's text mininghttps://conductscience.org/library/genes/5091NCBI Gene
PRKAA15562PubTator's text mininghttps://conductscience.org/library/genes/5562NCBI Gene
SPHK18877PubTator's text mininghttps://conductscience.org/library/genes/8877NCBI Gene
TNFRSF8943PubTator's text mininghttps://conductscience.org/library/genes/943NCBI Gene
TNFSF108743PubTator's text mininghttps://conductscience.org/library/genes/8743NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37908366

GET https://conductscience.org/api/papers/v1/37908366/references?page=2